Rick E Winningham Theravance Biopharma, Inc. (TBPH) insider trading activity

Rick E Winningham is CHIEF EXECUTIVE OFFICER of Theravance Biopharma, Inc.. Currently has a direct ownership of 1.81 Million shares of TBPH, which is worth approximately $17.4 Million. The most recent transaction as insider was on Feb 20, 2021, when has been sold 110,348 shares (Ordinary Shares) at a price of $18.79 per share, resulting in proceeds of $2,073,439. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.81M

0.7% 3M change

13.48% 12M change

Total Value Held $17.4 Million

Rick E Winningham Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 20 2021	SELL Payment of exercise price or tax liability	$2,073,439 $18.79 p/Share	110,348 Reduced 7.64%	1,334,821 Ordinary Shares
Feb 08 2021	BUY Grant, award, or other acquisition	-	170,000 Added 10.53%	1,445,169 Ordinary Shares
Nov 20 2020	SELL Payment of exercise price or tax liability	$240,011 $17.21 p/Share	13,946 Reduced 1.08%	1,275,169 Ordinary Shares

Also insider at

JAZZ

Jazz Pharmaceuticals plc Healthcare

Director

REW